{"transactions":[{"id":917452,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-05T21:30:13.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price on the initial filings was incorrectly stated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001771207-26-000005","document":"form4a-02052026_040210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000005/form4a-02052026_040210.xml","form_type":"4/A","original_submission_date":"2026-02-04"}},{"id":919148,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T22:52:05.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":136000,"derivative":{"underlying":"Common Shares","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001771207-26-000004","document":"form4-02042026_100201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000004/form4-02042026_100201.xml","form_type":"4"}},{"id":919147,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-04T22:52:05.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.97,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001771207-26-000004","document":"form4-02042026_100201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000004/form4-02042026_100201.xml","form_type":"4"}},{"id":928800,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-28T23:30:09.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":false,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":60300,"derivative":{"underlying":"Common Shares","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928799,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-28T23:30:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the option will vest on June 12, 2026 and 50% will vest on December 12, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-05-06","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928798,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:09.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":11180,"price":1.93,"value":21577.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":205406,"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928797,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:09.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":true,"shares":20100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive one common share."}],"balance_after":216586,"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928796,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:09.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":53566,"price":2.32,"value":124273.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":196486,"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928795,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a performance stock unit (\"PSU\") award that vested upon the certification by the Compensation Committee of the Board of Directors of the Issuer that the U.S. Food and Drug Administration has provided a New Drug Application Approval Letter granting approval of Cardamyst (etripamil)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU represents a contingent right to receive one common share."}],"balance_after":250052,"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":972424,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2025-12-11T21:15:10.000Z","date":"2025-12-09","kind":"gift","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift for no consideration to members of the Reporting Person's family outside the Reporting Person's household."}],"balance_after":150052,"source":{"system":"sec-edgar","filing":"0001771207-25-000002","document":"form4-12112025_041204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120725000002/form4-12112025_041204.xml","form_type":"4"}},{"id":1087240,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T20:15:12.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":66666,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001415889-25-019771","document":"form4-07152025_040705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019771/form4-07152025_040705.xml","form_type":"4"}},{"id":1087239,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T20:15:12.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":66666,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001415889-25-019771","document":"form4-07152025_040705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019771/form4-07152025_040705.xml","form_type":"4"}},{"id":1087238,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2025-07-15T20:15:12.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock."}],"balance_after":175052,"source":{"system":"sec-edgar","filing":"0001415889-25-019771","document":"form4-07152025_040705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019771/form4-07152025_040705.xml","form_type":"4"}},{"id":1291684,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-29T21:15:15.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":80400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":80400,"derivative":{"underlying":"Common Shares","underlying_shares":80400},"source":{"system":"sec-edgar","filing":"0001415889-25-002268","document":"form4-01292025_040111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925002268/form4-01292025_040111.xml","form_type":"4"}},{"id":1291683,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-29T21:15:15.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":120600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":120600,"derivative":{"exercise_price":2.02,"expiration_date":"2035-01-27","underlying":"Common Shares","underlying_shares":120600},"source":{"system":"sec-edgar","filing":"0001415889-25-002268","document":"form4-01292025_040111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925002268/form4-01292025_040111.xml","form_type":"4"}},{"id":2006705,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-17T21:52:55.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 16, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":105000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-02-16","underlying":"Common Shares","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-23-010707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919123010707/doc4.xml","form_type":"4"}},{"id":2319840,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option Grant (right to buy)","published_at":"2022-03-24T01:46:14.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on March 23, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":160000,"derivative":{"exercise_price":5.46,"expiration_date":"2032-03-21","underlying":"Common Shares","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001209191-22-020838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919122020838/doc4.xml","form_type":"4"}},{"id":2770302,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-27T00:37:53.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on March 24, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":6.26,"expiration_date":"2031-03-24","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-21-023350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919121023350/doc4.xml","form_type":"4"}},{"id":3044418,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-28T21:00:01.000Z","date":"2020-08-26","kind":"exercise","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The original grant was for 140,100 option shares. Twenty-five percent (25%) of the shares subject to the option vested on October 11, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":49754,"derivative":{"exercise_price":1.54,"expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-20-048651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120048651/doc4.xml","form_type":"4"}},{"id":3044417,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-08-28T21:00:01.000Z","date":"2020-08-26","kind":"exercise","acquired":true,"shares":5700,"price":1.54,"value":8778.0,"ownership":{"direct":true},"balance_after":108386,"source":{"system":"sec-edgar","filing":"0001209191-20-048651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120048651/doc4.xml","form_type":"4"}},{"id":3118193,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-06-08T22:59:47.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date."}],"balance_after":35000,"derivative":{"exercise_price":3.74,"expiration_date":"2030-06-05","underlying":"Common Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-035110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/doc4.xml","form_type":"4"}},{"id":3118192,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-06-08T22:59:47.000Z","date":"2020-04-03","kind":"exercise","acquired":false,"shares":18043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant was for 50,946 option shares. Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining\nshares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such\ndate."}],"balance_after":32903,"derivative":{"exercise_price":1.54,"expiration_date":"2028-10-15","underlying":"Common Shares","underlying_shares":18043},"source":{"system":"sec-edgar","filing":"0001209191-20-035110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/doc4.xml","form_type":"4"}},{"id":3118191,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-06-08T22:59:47.000Z","date":"2020-04-03","kind":"exercise","acquired":false,"shares":32528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The original grant was for 140,100 option shares. Twenty-five percent (25%) of the shares subject to the option vested on October 11, 2018, and\none thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person\ncontinuing to provide service through each such date."}],"balance_after":55454,"derivative":{"exercise_price":1.54,"expiration_date":"2027-10-11","underlying":"Common Shares","underlying_shares":32528},"source":{"system":"sec-edgar","filing":"0001209191-20-035110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/doc4.xml","form_type":"4"}},{"id":3118190,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-06-08T22:59:47.000Z","date":"2019-10-01","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The original grant was for 140,100 option shares. Twenty-five percent (25%) of the shares subject to the option vested on October 11, 2018, and\none thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person\ncontinuing to provide service through each such date."}],"balance_after":87982,"derivative":{"exercise_price":1.54,"expiration_date":"2027-10-11","underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-20-035110","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/doc4.xml","form_type":"4"}},{"id":3118189,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2020-06-08T22:59:47.000Z","date":"2020-04-03","kind":"exercise","acquired":true,"shares":18043,"price":1.54,"value":27786.22,"ownership":{"direct":true},"balance_after":102686,"source":{"system":"sec-edgar","filing":"0001209191-20-035110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/doc4.xml","form_type":"4"}},{"id":3118188,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2020-06-08T22:59:47.000Z","date":"2020-04-03","kind":"exercise","acquired":true,"shares":32528,"price":1.54,"value":50093.12,"ownership":{"direct":true},"balance_after":84643,"source":{"system":"sec-edgar","filing":"0001209191-20-035110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/doc4.xml","form_type":"4"}},{"id":3118187,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2020-06-08T22:59:47.000Z","date":"2019-10-01","kind":"exercise","acquired":true,"shares":2500,"price":1.54,"value":3850.0,"ownership":{"direct":true},"balance_after":52115,"source":{"system":"sec-edgar","filing":"0001209191-20-035110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120035110/doc4.xml","form_type":"4"}},{"id":3302534,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-24T22:35:14.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on January 23, 2021 and one forty-eighth (1/48th) of the shares subject to the option vest on each one month anniversary thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":60000,"derivative":{"exercise_price":21.48,"expiration_date":"2030-01-23","underlying":"Common Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-004895","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120004895/doc4.xml","form_type":"4"}}]}